News | October 18, 2010

Italian Man Surpasses 1,000 Days Of Support With Artificial Heart

October 18, 2010 - A 54-year-old Italian man has become the first patient to surpass 1,000 days of support with an artificial heart while waiting for a matching donor heart. The patient was implanted with the SynCardia temporary Total Artificial Heart.

“Life is a wonderful present that has to be respected,” said patient Pietro Zorzetto. “The Total Artificial Heart allowed me to recover to a very healthy physical condition. I really want to thank the SynCardia Total Artificial Heart for these unexpected 1,000 days of life.”

Zorzetto was first admitted to Azienda Ospedaliera di Padova on Nov. 30, 2007, suffering from valvular cardiomyopathy. Two previous operations at a different hospital had failed to repair his failing heart. Less than a week later, Zorzetto made history when he became the first patient in Italy to be implanted with the SynCardia Total Artificial Heart.

“The Total Artificial Heart provides excellent cardiac output, which restored our patient to normal condition despite the fact he presented with severe multi-organ failure,” said professor Gino Gerosa. “The Total Artificial Heart in combination with the portable driver has been extremely effective in providing the patient with a good quality of life with excellent exercise capacity.”

Zorzetto has been at home since Feb. 4, 2008, when he was discharged from the hospital using a portable driver to power his artificial heart. On a typical day, he walks 10 km and then exercises for an additional 30 minutes in his gym at home to stay in shape for a transplant.

For more information: www.syncardia.com

Related Content

Cardiogenic Shock Survival Rates Improve in Three Years Since Impella FDA Approval
News | Ventricular Assist Devices (VAD) | April 05, 2019
Three years ago this week, Abiomed's Impella heart pump received U.S. Food and Drug Administration (FDA) premarket...
HeartMate 3 Pump Shows Superior Outcomes in Advanced Heart Failure
News | Ventricular Assist Devices (VAD) | March 22, 2019
Severely ill patients with advanced heart failure who received the HeartMate 3 left ventricular assist device (LVAD)...
Leviticus Cardio and Jarvik Heart Unveil Wireless Heart Pump System
News | Ventricular Assist Devices (VAD) | February 11, 2019
Heart failure experts at the National Research Center for Cardiac Surgery in Astana, Kazakhstan, recently announced the...
Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
Technology | Ventricular Assist Devices (VAD) | July 17, 2018
Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive implant approach...
CorWave's Next-generation Neptune LVAD Receives Funding

Image courtesy of CorWave

News | Ventricular Assist Devices (VAD) | July 11, 2018
French-based CorWave announced that its CALYPSO program has received 14 million euros to develop CorWave Neptune, a new...
Abbott Recalls the HeartMate 3 Left Ventricular Assist System, LVAD
News | Ventricular Assist Devices (VAD) | May 23, 2018
Abbott has initiated a Class I recall of the HeartMate 3 Left Ventricular Assist System due to a malfunction in the...
FDA Approves Abiomed Impella CP With SmartAssist and Optical Sensor
Technology | Ventricular Assist Devices (VAD) | April 02, 2018
Abiomed Inc. announced that it received U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its...
Reduced Device Clotting, Decreased Strokes Seen With HeartMate 3 at Two Years
News | Ventricular Assist Devices (VAD) | March 13, 2018
At two years of follow-up, severely ill patients with advanced heart failure who received a novel heart pump fully...
Medtronic HeartWare HVAD System Approved for Destination Therapy
Technology | Ventricular Assist Devices (VAD) | October 04, 2017
October 4, 2017 — Medtronic received U.S.
Overlay Init